Join
Live feed
·
INSIDERFilingvia Quantisnow
Acrivon Therapeutics Inc. logo

President and CEO Blume-Jensen Peter covered exercise/tax liability with 13,729 shares (SEC Form 4) to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.
ACRV· Acrivon Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACRV (Acrivon Therapeutics Inc.) and more on Quantisnow.